The Vivekanand Cotspin IPO is a closed SME Bookbuilding offer (Fresh capital only) that opened on 21 September 2026. The Vivekanand Cotspin IPO closed on 23 September 2026, with an issue price of ₹37 per share. The Vivekanand Cotspin IPO has a face value of ₹10 and a lot size of 3,000 shares. The Vivekanand Cotspin IPO size aggregates up to ₹24 crore, listing on BSE SME on 28 September 2026. The Vivekanand Cotspin IPO allotment was scheduled for 24 September 2026.
On the financial front, the Vivekanand Cotspin IPO reported revenue of ₹409 crore for 31 Mar 2026, compared with ₹291 crore for 31 Mar 2025. The Vivekanand Cotspin IPO PAT was ₹4 crore against ₹4 crore. The Vivekanand Cotspin IPO EBITDA stood at ₹15 crore with a 3.70% margin. The Vivekanand Cotspin IPO net worth as of 31 Mar 2026 was ₹29 crore.
Always verify The Vivekanand Cotspin IPO details and GMP data with the official offer document before investing in the Vivekanand Cotspin IPO.
Financial Summary
Amount in ₹ Crore
Metric
31 Mar 2026
31 Mar 2025
31 Mar 2024
Total Assets
85
88
85
Revenue
409
291
358
PAT
4
4
3
EBITDA
15
15
15
Net Worth
29
17
21
Reserves
13
2
6
Total Borrowing
45
55
40
Vivekanand Cotspin IPO Financials FAQs
Revenue of Vivekanand Cotspin (Amount in ₹ Crore) — 31 Mar 2026: 409; 31 Mar 2025: 291; 31 Mar 2024: 358. Profit after tax (PAT) — 31 Mar 2026: 4; 31 Mar 2025: 4; 31 Mar 2024: 3.
EBITDA of Vivekanand Cotspin (Amount in ₹ Crore) — 31 Mar 2026: 15; 31 Mar 2025: 15; 31 Mar 2024: 15. The EBITDA margin is 3.70%.
Total assets — 31 Mar 2026: 85; 31 Mar 2025: 88; 31 Mar 2024: 85. Net worth — 31 Mar 2026: 29; 31 Mar 2025: 17; 31 Mar 2024: 21. Reserves & surplus — 31 Mar 2026: 13; 31 Mar 2025: 2; 31 Mar 2024: 6. (Amount in ₹ Crore)
Total borrowing of Vivekanand Cotspin (Amount in ₹ Crore) — 31 Mar 2026: 45; 31 Mar 2025: 55; 31 Mar 2024: 40. Debt-to-equity ratio: 1.56.
The financials shown for Vivekanand Cotspin IPO are taken from the company's offer document (DRHP/RHP/prospectus) filed with the exchange and SEBI, and are updated here when restated figures are published. Always cross-check with the official offer document before investing.
Look at the trend of revenue and PAT across periods, whether EBITDA is growing along with revenue, and whether net worth is rising while borrowings stay under control. The first column may be a part-year (interim) period, so compare full financial years with each other.
GMP and IPO data are unofficial and for information only — not investment advice.
Read the full disclaimer.
